While BPC-157 is generally regarded as having a very favorable safety profile in preclinical studies, some individuals do report transient digestive changes when they first begin using it
They come back the following week saying they do not feel much difference
GLP-1 medications are prescription treatments that activate GLP-1 receptors in the body
widerska M, Maciejczyk M, Zalewska A, Pogorzelska J, Flisiak R, Chabowski A (2019) Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD) Can plasma AGE be a marker of NAFLD
They quiet the brains hunger signals, slow digestion, and make it easier than ever to eat less
If symptoms are troublesome, your GP might recommend a brief course of a different treatment or a topical preparation to provide relief whilst your body adjusts